In a regulatory filing, Castle Biosciences disclosed that its director Daniel Bradbury sold 50K shares of common stock on July 7th in a total transaction size of $1.02M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CSTL:
- Castle Biosciences management to meet with BTIG
- Castle Biosciences stock up amid ADLT status for DecisionDx-SCC, says KeyBanc
- Castle Bio (NASDAQ:CSTL) Skyrockets after Novitas Drops Key Coverage Proposal
- Lake Street says Castle Biosciences received ‘double-bonus’ from CMS and Novitas
- Castle Biosciences to present new data on its gene expression profile at AHNS